Tesamorelin has shown effectiveness in reducing abdominal fat, specifically visceral fat, which is linked to several health issues like cardiovascular diseases and metabolic complications.
It is a synthetic peptide that acts as an analog of growth hormone-releasing hormone (GHRH). Tesamorelin works by stimulating the pituitary gland to release growth hormone, which in turn promotes the breakdown of abdominal fat cells.
By reducing visceral adipose tissue (fat around the organs), Tesamorelin helps improve body composition and may reduce the risk of metabolic complications associated with excess fat accumulation.